Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Institute of Diabetes for Diabetes, Obesity and Metabolism, USA.
Islets. 2010 Mar-Apr;2(2):121-3. doi: 10.4161/isl.2.2.10908.
Recently, we have reported the LIM-homeodoman (HD) transcriptional regulator, Islet-1 (Isl-1) as a key regulator for pancreatic islets after the secondary transition and into early postnatal stages in mice. Previously, the role of Isl-1 had only been examined during early pancreas development in vivo and cell lines. These early studies concluded that Isl-1 is required for the differentiation of early endocrine cells, and hormone gene expression is regulated by Isl-1 in cell culture. However, it was not clear from these studies whether the regulation of hormone gene transcription by Isl-1 was a direct transcriptional event. In addition, the function of Isl-1 during the formation of principle hormone producing endocrine cells had not been investigated since Isl-1 null animals die prior to the formation of these cells. Using pancreas-specific inactivation of Isl-1 in mice, we have elucidated the role of Isl-1 during maturation, proliferation and survival of the endocrine pancreas after the secondary transition. We have also identified MafA, a potent Insulin gene regulator, as the first direct target of Isl-1 in β-cells.
最近,我们报道了 LIM-homeodomain(HD)转录调节剂 Islet-1(Isl-1)作为小鼠次级转变后和早期出生后的胰腺胰岛的关键调节剂。此前,Isl-1 的作用仅在体内和细胞系的早期胰腺发育过程中进行了研究。这些早期研究得出的结论是,Isl-1 是早期内分泌细胞分化所必需的,并且激素基因表达在细胞培养中受到 Isl-1 的调控。然而,这些研究并不能明确 Isl-1 对激素基因转录的调节是否是直接的转录事件。此外,由于 Isl-1 缺失动物在这些细胞形成之前就已经死亡,因此在主要激素产生内分泌细胞形成过程中,Isl-1 的功能尚未得到研究。通过在小鼠中特异性失活胰腺中的 Isl-1,我们阐明了 Isl-1 在次级转变后内分泌胰腺的成熟、增殖和存活过程中的作用。我们还鉴定了 MafA,一种有效的胰岛素基因调节剂,作为 Isl-1 在β细胞中的第一个直接靶标。